Details of the Drug

General Information of Drug (ID: DMB6L97)

• Drug Name: GSK-2202083A

Indication

Disease Entry	ICD 11	Status	REF
Hepatitis B virus infection	1E51.0	Phase 2	[1]

• Cross-matching ID: TTD ID: D02NDC

References

• [1] ClinicalTrials.gov (NCT01090453) Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants. U.S. National Institutes of Health.